Renaissance Technologies’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,922
| Closed | -$25.9K | – | 3725 |
|
|
2024
Q3 | $25.9K | Sell |
19,922
-900
| -4% | -$1.17K | ﹤0.01% | 3414 |
|
|
2024
Q2 | $25.2K | Sell |
20,822
-600
| -3% | -$726 | ﹤0.01% | 3362 |
|
|
2024
Q1 | $46K | Sell |
21,422
-3,000
| -12% | -$6.44K | ﹤0.01% | 3496 |
|
|
2023
Q4 | $31K | Buy |
24,422
+8,300
| +51% | +$10.5K | ﹤0.01% | 3526 |
|
|
2023
Q3 | $22K | Buy |
16,122
+3,400
| +27% | +$4.64K | ﹤0.01% | 3515 |
|
|
2023
Q2 | $46K | Buy |
12,722
+1,505
| +13% | +$5.44K | ﹤0.01% | 3631 |
|
|
2023
Q1 | $44K | Buy |
11,217
+2,550
| +29% | +$10K | ﹤0.01% | 3687 |
|
|
2022
Q4 | $26K | Sell |
8,667
-12,114
| -58% | -$36.3K | ﹤0.01% | 3914 |
|
|
2022
Q3 | $113K | Sell |
20,781
-16,202
| -44% | -$88.1K | ﹤0.01% | 3552 |
|
|
2022
Q2 | $165K | Buy |
36,983
+5,571
| +18% | +$24.9K | ﹤0.01% | 3717 |
|
|
2022
Q1 | $279K | Sell |
31,412
-2,121
| -6% | -$18.8K | ﹤0.01% | 3501 |
|
|
2021
Q4 | $296K | Buy |
+33,533
| New | +$296K | ﹤0.01% | 3348 |
|